| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CFO, Cbo | President, CFO, Cbo &Sec'y +3 more
1 company
Palleiko Benjamin L is a Chief Executive Officer at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $12.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 9,999 | $11.88 | $118,743.12 | -3.2% | +13.0% | +134.6% | |
| May 19, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 3,808 | $11.84 | $45,097.38 | -1.3% | +10.5% | +121.8% | |
| Mar 7, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 6,669 | $11.97 | $79,827.93 | -2.3% | +15.8% | +35.7% | |
| Feb 18, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 5,104 | $9.82 | $50,142.72 | -1.8% | +23.4% | +58.0% | |
| Dec 9, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 7,627 | $9.75 | $74,363.25 | -2.7% | +28.4% | +73.0% | |
| Nov 18, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 14,400 | $9.26 | $133,293.60 | -5.1% | +5.2% | +53.4% | |
| Sep 9, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 7,352 | $12.19 | $89,621.62 | -2.8% | -21.3% | +31.5% | |
| Aug 19, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 14,215 | $12.01 | $170,769.06 | -5.5% | -24.0% | +4.7% | |
| Jun 7, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 7,465 | $11.53 | $86,068.46 | -3.2% | +10.2% | +23.0% | |
| May 20, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 21,959 | $11.76 | $258,336.66 | -9.2% | +3.0% | +3.0% |